XML 28 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Industry and Geographic Information
 9 Months Ended
Sep. 30, 2020
Industry And Geographic Information [Abstract]  
Industry and Geographic Information Industry and Geographic Information
The Company operates in one reportable segment. Sales to customers outside of the U.S. represented $140.5 million (16%) and $129.0 million (34%) of total revenue for the nine months ended September 30, 2020 and 2019, respectively. As of September 30, 2020 and December 31, 2019, net accounts receivable due from foreign customers were $18.9 million and $22.9 million, respectively.
The Company had sales to individual customers in excess of 10% of total revenues, as follows:
Nine Months Ended
September 30,
20202019
Customer:
A25 %13 %
B18 %17 %
C11 %6 %
D9 %15 %
Total:63 %51 %
As of September 30, 2020 and December 31, 2019, net accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $226.9 million and $53.5 million, respectively.
Consolidated total revenues by product category for the three and nine months ended September 30, 2020 and 2019 were as follows (in thousands):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2020201920202019
Rapid Immunoassay$337,042 $42,534 $513,578 $126,800 
Cardiometabolic Immunoassay64,810 66,820 172,902 200,674 
Specialized Diagnostic Solutions11,213 12,455 39,452 40,595 
Molecular Diagnostic Solutions62,993 4,683 126,533 14,643 
Total revenues$476,058 $126,492 $852,465 $382,712